Relmada Therapeutics (RLMD) Short Interest Ratio & Short Volume $0.37 +0.02 (+4.40%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$0.37 +0.00 (+1.34%) As of 05/2/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Relmada Therapeutics Short Interest DataRelmada Therapeutics (RLMD) has a short interest of 1.41 million shares, representing 5.70% of the float (the number of shares available for trading by the public). This marks a -12.96% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 882,275 shares to cover all short positions.Current Short Interest1,410,000 sharesPrevious Short Interest1,620,000 sharesChange Vs. Previous Month-12.96%Dollar Volume Sold Short$434,280.00Short Interest Ratio0.8 Days to CoverLast Record DateApril 15, 2025Outstanding Shares33,192,000 sharesShort Percent of Float5.70%Today's Trading Volume1,196,329 sharesAverage Trading Volume882,275 sharesToday's Volume Vs. Average136% Short Selling Relmada Therapeutics? Sign up to receive the latest short interest report for Relmada Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRLMD Short Interest Over TimeRLMD Days to Cover Over TimeRLMD Percentage of Float Shorted Over Time Relmada Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20251,410,000 shares $434,280.00 -13.0%5.7%0.8 $0.31 3/31/20251,620,000 shares $437,400.00 +8.7%6.5%1.7 $0.27 3/15/20251,490,000 shares $436,123.00 +18.3%6.0%1.4 $0.29 2/28/20251,260,000 shares $327,600.00 -28.0%5.1%0.8 $0.26 2/15/20251,750,000 shares $582,575.00 +108.8%7.1%1.1 $0.33 1/31/2025838,000 shares $292,462.00 -33.0%N/A0.6 $0.35 1/15/20251,250,000 shares $495,625.00 -24.2%N/A1.3 $0.40 12/31/20241,650,000 shares $858,000.00 -7.3%N/A1.7 $0.52 12/15/20241,780,000 shares $653,260.00 +67.9%N/A2.3 $0.37 11/30/20241,060,000 shares $3.20 million -7.8%N/A1.6 $3.02 Get the Latest News and Ratings for RLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/20241,150,000 shares $3.46 million -3.4%N/A6.1 $3.01 10/31/20241,190,000 shares $4.14 million -5.6%N/A6.7 $3.48 10/15/20241,260,000 shares $4.38 million +0.8%N/A6.9 $3.48 9/30/20241,250,000 shares $4.05 million +5.9%N/A6.6 $3.24 9/15/20241,180,000 shares $3.65 million -2.5%N/A6.6 $3.09 8/31/20241,210,000 shares $3.39 million -6.2%N/A10.8 $2.80 8/15/20241,290,000 shares $3.32 million -3.0%N/A11.5 $2.57 7/31/20241,330,000 shares $4.87 million -2.2%N/A12.2 $3.66 7/15/20241,360,000 shares $5.22 million +34.7%N/A13.1 $3.84 6/30/20241,010,000 shares $3.03 million -34.8%N/A9.6 $3.00 6/15/20241,550,000 shares $4.67 million +0.7%N/A14.9 $3.01 5/31/20241,540,000 shares $4.62 million -1.9%N/A11.1 $3.00 5/15/20241,570,000 shares $5.46 million -4.3%N/A10.6 $3.48 4/30/20241,640,000 shares $5.97 million -4.1%N/A9.4 $3.64 4/15/20241,710,000 shares $7.61 million +1.2%N/A8.1 $4.45 3/31/20241,690,000 shares $7.86 million -3.4%N/A7.4 $4.65 3/15/20241,750,000 shares $9.49 million No ChangeN/A5.4 $5.42 2/29/20241,750,000 shares $10.72 million +1.2%N/A5.5 $6.13 2/15/20241,730,000 shares $9.12 million +7.5%N/A5.6 $5.27 1/31/20241,610,000 shares $6.33 million +3.2%N/A5.6 $3.93 1/15/20241,560,000 shares $4.90 million +92.4%N/A6.3 $3.14 12/31/2023810,700 shares $3.36 million +26.9%N/A3.3 $4.14 12/15/2023638,800 shares $1.58 million -26.2%N/A3.7 $2.48 11/30/2023865,800 shares $2.14 million -1.1%N/A5.3 $2.47 11/15/2023875,200 shares $2.65 million +10.1%N/A5.6 $3.03 10/31/2023794,700 shares $2.38 million +13.4%N/A5 $2.99 10/15/2023700,900 shares $2.17 million -2.5%N/A4.6 $3.10 9/30/2023718,700 shares $2.16 million +6.1%N/A4.9 $3.00 9/15/2023677,500 shares $2.09 million +9.7%N/A4.5 $3.09 8/31/2023617,700 shares $2.09 million -10.5%N/A3.8 $3.38URGENT: Someone's Moving Gold Out of London... (Ad)People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. Go here to learn about my Top Four picks for the coming bull mania. 8/15/2023689,800 shares $2.35 million -18.8%N/A4.1 $3.41 7/31/2023849,900 shares $2.23 million -11.0%N/A4.8 $2.62 7/15/2023954,400 shares $2.71 million -9.1%N/A5 $2.84 6/30/20231,050,000 shares $2.58 million -46.7%N/A5.2 $2.46 6/15/20231,970,000 shares $5.02 million -5.3%N/A8.7 $2.55 5/31/20232,080,000 shares $5.91 million +16.9%N/A11.3 $2.84 5/15/20231,780,000 shares $5.50 million -3.3%N/A9.1 $3.09 4/30/20231,840,000 shares $4.64 million +0.6%N/A9.1 $2.52 4/15/20231,830,000 shares $4.96 million +4.0%N/A8.5 $2.71 3/31/20231,760,000 shares $3.98 million +13.6%N/A6.6 $2.26 3/15/20231,550,000 shares $3.97 million +6.2%N/A5 $2.56 2/28/20231,460,000 shares $5.26 million -8.8%N/A2.5 $3.60 2/15/20231,600,000 shares $5.94 million No ChangeN/A2.5 $3.71 1/31/20231,600,000 shares $6.50 million -20.4%N/A2.2 $4.06 1/15/20232,010,000 shares $8.28 million +12.3%N/A2.4 $4.12 12/30/20221,790,000 shares $6.25 million +4.1%N/A1.4 $3.49 12/15/20221,720,000 shares $5.40 million -13.6%N/A1.3 $3.14 11/30/20221,990,000 shares $9.25 million -28.2%N/A1.6 $4.65 11/15/20222,770,000 shares $16.32 million -4.2%N/A2.6 $5.89 10/31/20222,890,000 shares $18.47 million -13.7%N/A2.9 $6.39 10/15/20223,350,000 shares $20.77 million -26.2%N/A3.8 $6.20 9/30/20224,540,000 shares $168.07 million +25.1%N/A12.3 $37.02 9/15/20223,630,000 shares $124.84 million +11.7%N/A11.3 $34.39 8/31/20223,250,000 shares $94.71 million +3.2%N/A11.9 $29.14 8/15/20223,150,000 shares $91.79 million +1.0%N/A12.3 $29.14 7/31/20223,120,000 shares $79.87 million +1.0%N/A12.1 $25.60 7/15/20223,090,000 shares $69.43 million -4.9%N/A11.7 $22.47 6/30/20223,250,000 shares $61.72 million +21.7%N/A12 $18.99 6/15/20222,670,000 shares $44.59 million +1.1%N/A9.5 $16.70 5/31/20222,640,000 shares $49.61 million +21.1%N/A9.2 $18.79 5/15/20222,180,000 shares $43.16 million +32.9%N/A6.6 $19.80 4/30/20221,640,000 shares $41.18 million -4.7%N/A5.1 $25.11 4/15/20221,720,000 shares $44.77 million -4.4%N/A5.5 $26.03 3/31/20221,800,000 shares $48.58 million +23.3%N/A5.9 $26.99 3/15/20221,460,000 shares $32.49 million -11.0%N/A5.2 $22.25 2/28/20221,640,000 shares $33.64 million +34.4%N/A5.9 $20.51 2/15/20221,220,000 shares $24.40 million -8.3%N/A5.1 $20.00 1/31/20221,330,000 shares $24.46 million -21.3%N/A6.6 $18.39 1/15/20221,690,000 shares $33.56 million +24.3%10.7%10 $19.86 12/31/20211,360,000 shares $30.64 million +40.7%8.6%8.6 $22.53 12/15/2021966,900 shares $19.51 million +7.7%6.1%7.1 $20.18 11/30/2021897,600 shares $16.03 million +2.9%5.7%8.2 $17.86 11/15/2021872,400 shares $19.79 million -2.8%5.5%9.2 $22.69 10/29/2021897,500 shares $21.06 million -5.9%5.7%8.2 $23.47 10/15/2021953,300 shares $22.53 million -4.3%6.1%4.1 $23.63 9/30/2021996,200 shares $26.11 million -2.3%6.3%4.1 $26.21 9/15/20211,020,000 shares $27.31 million -1.0%6.5%4.2 $26.77 8/31/20211,030,000 shares $24.63 million +12.1%6.6%4.4 $23.91 8/13/2021918,600 shares $20.99 million +30.5%5.9%3.9 $22.85 7/30/2021704,000 shares $18.30 million -11.9%4.3%3.1 $26.00URGENT: Someone's Moving Gold Out of London... (Ad)People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. Go here to learn about my Top Four picks for the coming bull mania. 7/15/2021798,800 shares $25.20 million -11.7%4.9%8.1 $31.55 6/30/2021904,100 shares $28.94 million -6.5%5.5%10.1 $32.01 6/15/2021966,400 shares $30.92 million -6.2%5.9%11.3 $32.00 5/28/20211,030,000 shares $35.63 million +13.8%6.3%12.5 $34.59 5/14/2021904,800 shares $30.31 million +6.6%5.5%12.2 $33.50 4/30/2021849,000 shares $32.97 million -1.7%5.5%12.9 $38.83 4/15/2021863,500 shares $31.95 million +6.4%5.6%12 $37.00 3/31/2021811,600 shares $28.35 million +13.9%5.3%11.1 $34.93 3/15/2021712,800 shares $26.14 million -8.3%4.8%9.1 $36.67 2/26/2021777,600 shares $26.31 million -12.4%5.2%10 $33.84 2/12/2021887,200 shares $31.97 million -4.8%6.0%11.5 $36.03 1/29/2021931,800 shares $30.39 million -4.3%6.3%12.3 $32.61 1/15/2021974,000 shares $36.64 million +5.6%6.5%11.6 $37.62 12/31/2020922,000 shares $29.04 million +4.0%6.2%9.9 $31.50 12/15/2020886,600 shares $29.78 million -10.2%6.0%9.4 $33.59 11/30/2020987,300 shares $35.53 million -2.3%6.6%10.6 $35.99 11/15/20201,010,000 shares $32.90 million +1.1%6.8%10.9 $32.57 10/30/2020998,600 shares $31.12 million -18.8%6.8%10.9 $31.16 10/15/20201,230,000 shares $44.72 million -30.5%8.4%14.4 $36.36 RLMD Short Interest - Frequently Asked Questions What is Relmada Therapeutics' current short interest? Short interest is the volume of Relmada Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 1,410,000 shares of RLMD short. 5.70% of Relmada Therapeutics' shares are currently sold short. Learn More on Relmada Therapeutics' current short interest. What is a good short interest ratio for Relmada Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLMD shares currently have a short interest ratio of 1.0. Learn More on Relmada Therapeutics's short interest ratio. Which institutional investors are shorting Relmada Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Relmada Therapeutics: Group One Trading LLC, Citadel Advisors LLC, Rosalind Advisors Inc., Concourse Financial Group Securities Inc., and Rosalind Advisors Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Relmada Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.70% of Relmada Therapeutics' floating shares are currently sold short. Is Relmada Therapeutics' short interest increasing or decreasing? Relmada Therapeutics saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 1,410,000 shares, a drop of 13.0% from the previous total of 1,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Relmada Therapeutics' short interest compare to its competitors? 5.70% of Relmada Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Relmada Therapeutics: Outlook Therapeutics, Inc. (19.49%), Anebulo Pharmaceuticals, Inc. (0.19%), Forte Biosciences, Inc. (1.97%), Mural Oncology plc (3.95%), Connect Biopharma Holdings Limited (0.15%), Iterum Therapeutics plc (3.67%), Atara Biotherapeutics, Inc. (17.61%), FibroBiologics, Inc. (5.23%), Century Therapeutics, Inc. (8.99%), Oncolytics Biotech Inc. (3.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Relmada Therapeutics stock? Short selling RLMD is an investing strategy that aims to generate trading profit from Relmada Therapeutics as its price is falling. RLMD shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Relmada Therapeutics? A short squeeze for Relmada Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RLMD, which in turn drives the price of the stock up even further. How often is Relmada Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLMD, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Outlook Therapeutics Short Interest Anebulo Pharmaceuticals Short Interest Forte Biosciences Short Interest Mural Oncology Short Interest Connect Biopharma Short Interest Iterum Therapeutics Short Interest Atara Biotherapeutics Short Interest FibroBiologics Short Interest Century Therapeutics Short Interest Oncolytics Biotech Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLMD) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relmada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RLMD Stock Free RLMD Stock Alerts